ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 85 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $11,570,000 | -44.3% | 216,460 | +17.8% | 0.02% | -44.4% |
| Q4 2015 | $20,766,000 | -2.0% | 183,818 | +2.1% | 0.03% | -6.9% |
| Q3 2015 | $21,189,000 | +82.3% | 180,008 | +19.9% | 0.03% | +107.1% |
| Q2 2015 | $11,622,000 | +73.3% | 150,095 | +29.5% | 0.01% | +55.6% |
| Q1 2015 | $6,706,000 | +81.9% | 115,920 | +1.4% | 0.01% | +80.0% |
| Q4 2014 | $3,687,000 | +44.8% | 114,324 | +9.8% | 0.01% | +25.0% |
| Q3 2014 | $2,547,000 | +39.2% | 104,092 | +0.8% | 0.00% | +100.0% |
| Q2 2014 | $1,830,000 | +30.2% | 103,220 | +46.9% | 0.00% | 0.0% |
| Q1 2014 | $1,406,000 | +20.5% | 70,245 | +1.0% | 0.00% | 0.0% |
| Q4 2013 | $1,167,000 | +52.7% | 69,573 | -3.2% | 0.00% | +100.0% |
| Q3 2013 | $764,000 | +107.0% | 71,905 | +8.9% | 0.00% | 0.0% |
| Q2 2013 | $369,000 | – | 66,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |